A safety and efficacy study of lumasiran, an investigational RNA interference (RNAi) therapeutic, in adult and pediatric patients with primary hyperoxaluria type 1

2019 ◽  
Vol 18 (1) ◽  
pp. e388-e389 ◽  
Author(s):  
Y. Frishberg ◽  
G. Deschenes ◽  
P. Cochat ◽  
D. Magen ◽  
J. Groothoff ◽  
...  
Keyword(s):  
Rna Interference ◽  
Pediatric Patients ◽  
Primary Hyperoxaluria ◽  
Efficacy Study ◽  
Primary Hyperoxaluria Type 1 ◽  
Safety And Efficacy ◽  
Primary Hyperoxaluria Type ◽  
Hyperoxaluria Type

Generation of a mouse model of Primary Hyperoxaluria Type 1 via CRISPR/Cas9 mediated gene editing

2019 ◽  
pp. 28-39
Author(s):  
Kimberly Coughlan ◽  
Rajanikanth Maganti ◽  
Andrea Frassetto ◽  
Christine DeAntonis ◽  
Meredith Wolfrom ◽  
...  
Keyword(s):  
Mouse Model ◽  
Gene Editing ◽  
Primary Hyperoxaluria ◽  
Primary Hyperoxaluria Type 1 ◽  
Primary Hyperoxaluria Type ◽  
Hyperoxaluria Type

scholarly journals POS-111 I244T MUTATION IN PRIMARY HYPEROXALURIA TYPE 1: A MUTATION WITH ATYPICAL COURSE

2021 ◽  
Vol 6 (4) ◽  
pp. S46
Author(s):  
R. DAHMANE ◽  
S. Mrabet ◽  
N. Thabet ◽  
D. Zallema ◽  
W. Sahtout ◽  
...  
Keyword(s):  
Primary Hyperoxaluria ◽  
Primary Hyperoxaluria Type 1 ◽  
Primary Hyperoxaluria Type ◽  
Hyperoxaluria Type

Hypercalcaemia complicating systemic oxalosis in primary hyperoxaluria type 1

1995 ◽  
Vol 10 (supp8) ◽  
pp. 17-21 ◽  
Author(s):  
C. Toussaint ◽  
L. De Pauw ◽  
C. Tielemans ◽  
D. Abramowicz
Keyword(s):  
Primary Hyperoxaluria ◽  
Primary Hyperoxaluria Type 1 ◽  
Primary Hyperoxaluria Type ◽  
Hyperoxaluria Type
Sign in / Sign up

Export Citation Format

Share Document